Long-standing criticisms of academic publishing are helping to fuel the Trump administration’s attacks on the nation’s scientific enterprise. “We all know there are enormous problems facing science and scientific publishing. Influence from the pharmaceutical industry is a concern editors of medical journals have also raised. “Kennedy is right that the dependence of medical research on pharmaceutical funding is a problem,” the former editors wrote. But opening access to scientific research won’t be enough to restore public trust in science, said Meagan Phelan, communications director for the Science family of journals.